𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Transfusion independence in patients with myelodysplastic syndromes : Impact on outcomes and quality of life

✍ Scribed by Lodovico Balducci

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
161 KB
Volume
106
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Red blood cell transfusions and iron ove
Red blood cell transfusions and iron overload in the treatment of patients with myelodysplastic syndromes
✍ Elias Jabbour; Hagop M. Kantarjian; Charles Koller; Ali Taher πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 185 KB πŸ‘ 2 views

## Abstract ## BACKGROUND Approximately 15,000 new cases of myelodysplastic syndromes (MDS) are expected in the United States each year. ## METHODS The mainstay for the management of myelodysplastic syndromes (MDS) is supportive therapy with red blood cell (RBC) transfusions to improve the patie

International MDS risk analysis workshop
International MDS risk analysis workshop (IMRAW)/IPSS reanalyzed: Impact of cytopenias on clinical outcomes in myelodysplastic syndromes
✍ Jelena M. Kao; Alex McMillan; Peter L. Greenberg πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 169 KB πŸ‘ 1 views

## Abstract The International Prognostic Scoring System (IPSS) was created for evaluating clinical outcomes of patients with myelodysplastic syndromes (MDS). We evaluated the depth of cytopenias to determine whether this parameter could further refine the prognostic ability of the IPSS. Correlation